Amgen
Search results
Jun 13, 2024 · Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.
About Us. At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down ...
Gilead Sciences, Inc. (/ ˈ ɡ ɪ l i ə d /) is an American biopharmaceutical company headquartered in Foster City, California that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.Gilead is a member of the NASDAQ Biotechnology Index and the S&P 500.. Gilead was founded in 1987 under the name Oligogen by Michael L. Riordan. The original name was a ...
Gilead Sciences | 631,194 followers on LinkedIn. Creating Possible | At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology ...
Gilead Sciences is a biopharmaceutical company that researches, develops, and sells therapies for treating HIV, hepatitis B, hepatitis C, and certain cancers. In October 2020, Gilead's Veklury ...
At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in ...
At Gilead, we’re committed to creating possible. For more than 30 years, we’ve pursued the impossible, chased it down, tackled it for answers and surrounded it for a way in. We have worked tirelessly to bring forward medicines for life-threatening diseases and improving care for people across Canada and around the world.
Advancing Global Health. We invest in programmes that aim to eliminate some of the world’s most challenging public health threats, enable access to medicines and help fight the stigma that prevents people from seeking care.
Investor Relations. At Gilead, we’re committed to creating a healthier world for everyone – no matter the challenges ahead of us. For more than 30 years, we’ve pursued the impossible, chased it down, tackled it for answers and surrounded it for a way in. We have worked tirelessly to bring forward medicines for life-threatening diseases.
For more than 30 years, Gilead’s research program has achieved advancements that were once thought impossible. As we bring new products into clinical development, our goal remains the same – to discover, develop and commercialize therapeutics that transform care for people around the world. Our research and development programs currently ...
